{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:21:38Z","timestamp":1791044498911,"version":"4.1.0"},"reference-count":24,"publisher":"Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Infect Dis"],"published-print":{"date-parts":[[2013]]},"DOI":"10.7883\/yoken.66.46","type":"journal-article","created":{"date-parts":[[2013,1,21]],"date-time":"2013-01-21T22:45:13Z","timestamp":1358808313000},"page":"46-50","source":"Crossref","is-referenced-by-count":3,"title":["Production of a Neutralizing Mouse-Human Chimeric Antibody against Botulinum Neurotoxin Serotype E"],"prefix":"10.7883","volume":"66","author":[{"given":"Masafumi","family":"Mukamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Kohda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikateru","family":"Nozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohide","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"Kozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4631","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Simpson, L. (1981): The origin, structure, and pharmacological activity of botulinum toxin. Pharmacol. Rev., 33, 155–188.","DOI":"10.1016\/S0031-6997(25)06852-8"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.44.101802.121554"},{"key":"3","unstructured":"4. Midura, T.F. and Arnon, S.S. (1976): Infant botulism: identification of Clostridium botulinum<\/i> and its toxins in faeces. Lancet, 2, 934–936."},{"key":"4","unstructured":"5. Fenicia, L. and Anniballi, F. (2009): Infant botulism. Ann. 1st Super. Sanita., 45, 134–146."},{"key":"5","unstructured":"6. Yoshikawa, S., Kawai, T. and Kumeda, Y. (2012): Infantile botulism—31st domestic case in Japan, October 2011—Sakai City. Infect. Agents Surveillance Rep., 33, 100–101 (in Japanese)."},{"key":"6","unstructured":"7. Dykes, Y.H., Luquez, C., Raphael, B.H., et al. (2008): Laboratory investigation of the first case of Clostridium botulinum<\/i> type E infant botulism in the United States. Abstract. p. 45. 45th Interagency Botulism Res. Coord. Comm. Meet., Philadelphia, Pa."},{"key":"7","unstructured":"8. Fenicia, L., Anniballi, F. and Aureli, P. (2007): Intestinal toxemia botulism in Italy. Eur. J. Clin. Micribiol. Infect. Dis., 26, 385–394."},{"key":"8","doi-asserted-by":"crossref","unstructured":"9. Abe, Y., Nagasawa, T., Monma, C., et al. (2008): Infantile botulism caused by Clostridium butyricum<\/i> type E toxin. Pediatr. Neurol., 38, 55–57.","DOI":"10.1016\/j.pediatrneurol.2007.08.013"},{"key":"9","unstructured":"10. Koepke, R., Sobel, J. and Arnon, S.S. (2008): Global occurrence of infant botulism. Pediatrics, 122, e73–82."},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1128\/JB.01180-06"},{"key":"11","doi-asserted-by":"crossref","unstructured":"13. McCroskey, L.M., Hatheway, C.L., Fenicia, L., et al. (1986): Characterization of an organism that produces type E botulinal toxin but which resembles Clostridium butyricum<\/i> from the feces of an infant with type E botulism. J. Clin. Microbiol., 23, 201–202.","DOI":"10.1128\/JCM.23.1.201-202.1986"},{"key":"12","doi-asserted-by":"crossref","unstructured":"14. Arnon, S.S., Schechter, R., Maslanka, S.E., et al. (2006): Human botulism immune globulin for the treatment of infant botulism. N. Engl. J. Med., 354, 462–471.","DOI":"10.1056\/NEJMoa051926"},{"key":"13","doi-asserted-by":"crossref","unstructured":"15. Kozaki, S., Miki, A., Kamata, Y., et al. (1989): Immunological characterization of papain-induced fragments of Clostridium botulinum<\/i> type A neurotoxin and interaction of the fragments with brain synaptosomes. Infect. Immunol., 57, 2634–2639.","DOI":"10.1128\/IAI.57.9.2634-2639.1989"},{"key":"14","unstructured":"16. Tsuzuki, K., Yokosawa, N., Syuto, B., et al. (1988): Establishment of a monoclonal antibody recognizing an antigenic site common to Clostridium botulinum<\/i> type B, C1<\/sub>, D, and E toxins and tetanus toxin. Infect. Immun., 56, 898–902."},{"key":"15","unstructured":"17. Schroff, R., Foon, K., Beatty, S., et al. (1985): Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy. Cancer Res., 45, 879–885."},{"key":"16","doi-asserted-by":"crossref","unstructured":"18. Shawler, D., Bartholomew, R., Smith, L., et al. (1985): Human immune response to multiple injections of murine monoclonal IgG. J. Immunol., 135, 1530–1535.","DOI":"10.4049\/jimmunol.135.2.1530"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1038\/312643a0"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.81.21.6851"},{"key":"19","doi-asserted-by":"crossref","unstructured":"22. Kitamura, M., Sakaguchi, S. and Sakaguchi, G. (1968): Purification and some properties of Clostridium botulinum<\/i> type-E toxin. Biochim. Biophys. Acta, 168, 207–217.","DOI":"10.1016\/0005-2795(68)90144-X"},{"key":"20","doi-asserted-by":"crossref","unstructured":"23. Kozaki, S., Onimaru, J., Kamata, Y., et al. (1991): Immunological characterization of Clostridium butyricum<\/i> neurotoxin and its trypsin-induced fragment by use of monoclonal antibodies against Clostridium botulinum<\/i> type E neurotoxin. Infect. Immun., 59, 457–459.","DOI":"10.1128\/IAI.59.1.457-459.1991"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1006\/abio.1976.9999"},{"key":"22","doi-asserted-by":"crossref","unstructured":"26. Kabat, E., Wu, T. and Bilofsky, H. (1979): Evidence supporting somatic assembly of the DNA segments (minigenes), coding for the framework, and complementarity-determining segments of immunoglobulin variable regions. J. Exp. Med., 149, 1299–1313.","DOI":"10.1084\/jem.149.6.1299"},{"key":"23","doi-asserted-by":"crossref","unstructured":"28. Mah, D.C.W., Hu, W.G., Pon, J.K., et al. (2003): Recombinant anti-botulinum neurotoxin A single-chain variable fragment antibody generated using a phage display system. Hybridoma Hybrisomics, 22, 277–283.","DOI":"10.1089\/153685903322538791"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.11.4220"}],"container-title":["Japanese Journal of Infectious Diseases"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T18:01:38Z","timestamp":1745949698000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/66\/1\/66_46\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.7883\/yoken.66.46","relation":{},"ISSN":["1344-6304"],"issn-type":[{"value":"1344-6304","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]}}}